Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo

Signal transduction modifiers that modulate the lysophosphatidic acid (LPA) pathway have potential as anticancer agents. Herein, we describe metabolically stabilized LPA analogues that reduce cell migration and invasion and cause regression of orthotopic breast tumors in vivo. Two diastereoisomeric...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhang, Honglu, Xu, Xiaoyu, Gajewiak, Joanna, Tsukahara, Ryoko, Fujiwara, Yuko, Liu, Jianxiong, Fells, James I., Perygin, Donna, Parrill, Abby L., Tigyi, Gabor, Prestwich, Glenn D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446773/
https://ncbi.nlm.nih.gov/pubmed/19509223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-0302
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi